SAREPTA THERAPEUTICS, INC. (SRPT) Net margin 2016–2025
SAREPTA THERAPEUTICS, INC. (SRPT) net profit margin by fiscal year — reported net income divided by reported revenue.
-38.3%FY2025 · since FY2016: -4930.2% → -38.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -38.3% | -51.4 pp |
| FY2024 | 13.2% | +60.0 pp |
| FY2023 | -46.8% | +36.6 pp |
| FY2022 | -83.4% | -15.0 pp |
| FY2021 | -68.4% | +53.2 pp |
| FY2020 | -121.6% | +66.2 pp |
| FY2019 | -187.8% | -67.5 pp |
| FY2018 | -120.2% | -87.4 pp |
| FY2017 | -32.8% | +4897.4 pp |
| FY2016 | -4930.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More SRPT financial trends
SRPT RevenueSRPT Net incomeSRPT Gross profitSRPT Gross marginSRPT Operating incomeSRPT Operating marginSRPT Operating cash flowSRPT Free cash flowSRPT Capital expendituresSRPT Return on equitySRPT Stock buybacksSRPT Dividends paidSRPT Total assetsSRPT Total liabilitiesSRPT Shareholders’ equitySRPT overview →